Bulletin
Investor Alert

GSK PLC ADR

NYS: GSK

GO
/marketstate/country/us

After Hours

GSK
/zigman2/quotes/209463850/composite

$

35.92

Change

-0.05 -0.14%

Volume

Volume 40,263

Dec 9, 2022, 7:06 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/209463850/composite

Previous close

$ 36.60

$ 35.97

Change

-0.63 -1.72%

Day low

Day high

$35.94

$36.50

Open
Open: 36.38

52 week low

52 week high

$28.47

$47.82

Open

Market cap

$73.79B

Average volume

6.43M

P/E ratio

4.42

Rev. per Employee

$486,707

EPS

8.14

Dividend

0.37

Div yield

5.56%

Ex dividend date

8/18/22

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/gsk

MarketWatch News on GSK

  1. Zantac Lawsuits Get Tossed. 3 Drug Stocks Soar on the News.

    5:09 p.m. Dec. 6, 2022

    - Josh Nathan-Kazis

  2. GSK stock price target cut to GBP15.50 from GBP19.75 at Citi Research

    6:18 a.m. Dec. 1, 2022

    - Tomi Kilgore

  3. GSK Pulls Cancer Drug After Trial Failure

    10:59 a.m. Nov. 22, 2022

    - Josh Nathan-Kazis

  4. GSK Stock Drops as Cancer Drug Disappoints

    11:40 a.m. Nov. 7, 2022

    - Josh Nathan-Kazis

  5. Pfizer Will Dominate RSV Vaccine Market, CEO Says

    2:40 p.m. Nov. 1, 2022

    - Josh Nathan-Kazis

  6. Pfizer Scores a Beat and Is High on RSV Vaccine

    8:30 a.m. Nov. 1, 2022

    - Josh Nathan-Kazis

  7. Pfizer's Vaccine Prices Will Be Key Today

    1:15 a.m. Nov. 1, 2022

    - Josh Nathan-Kazis

  8. J&J Earnings Top Estimates. The CFO Explains What Went Right.

    10:07 a.m. Oct. 18, 2022

    - Josh Nathan-Kazis

  9. GSK, Pfizer Duel Over RSV Vaccine Is Heating Up

    11:04 a.m. Oct. 13, 2022

    - Josh Nathan-Kazis

  10. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/gsk

Other News on GSK

  1. What You Should Know About Treating Covid-19

    3:31 p.m. Dec. 7, 2022

    - Jared S. Hopkins

  2. Haleon Proves Its Mettle After GSK Spinoff

    5:17 p.m. Dec. 6, 2022

    - GuruFocus.com

  3. GSK's Myelofibrosis Candidate MAA Gets Accepted in Europe

    10:36 a.m. Dec. 5, 2022

    - Zacks.com

  4. FDA Takes Tougher Line on Fast-Tracked Drugs

    5:30 a.m. Dec. 5, 2022

    - Liz Essley Whyte

  5. Why Is Glaxo (GSK) Up 6.7% Since Last Earnings Report?

    11:31 a.m. Dec. 2, 2022

    - Zacks.com

  6. Goldseek Closes $831,500 Private Placement

    8:00 a.m. Nov. 30, 2022

    - TheNewswire.ca

  7. GSK to Withdraw Blenrep From U.S. Market on FDA Request

    9:59 a.m. Nov. 23, 2022

    - Zacks.com

  8. Top 5 3rd Quarter Trades of Parallax Volatility Advisers, L.P.

    10:00 p.m. Nov. 21, 2022

    - GuruFocus.com

  9. Cladis Investment Advisory, LLC Buys 3, Sells 2 in 3rd Quarter

    8:00 a.m. Nov. 18, 2022

    - GuruFocus.com

  10. Top 5 3rd Quarter Trades of CLARK ESTATES INC/NY

    4:00 p.m. Nov. 16, 2022

    - GuruFocus.com

  11. Loading more headlines...
/news/pressrelease/company/us/gsk

Press Releases on GSK

  1. Goldseek Closes $831,500 Private Placement

    8:00 a.m. Nov. 30, 2022

    - TheNewswire.ca

  2. GOLDSEEK Announces Private Placement

    3:30 p.m. Nov. 4, 2022

    - TheNewswire.ca

  3. Cheap Stocks To Buy Now? Hot Penny Stocks To Watch In October

    5:34 p.m. Sept. 30, 2022

    - Penny Stocks

  4. Reddit Penny Stocks to Watch as September Ends

    5:00 a.m. Sept. 23, 2022

    - Penny Stocks

  5. Pfizer Stock up on Late-Stage Trials for New Vaccine

    5:04 p.m. Sept. 22, 2022

    - PressReach.com

  6. Micro Cap Up Over +100% In Premarket

    9:06 a.m. Sept. 22, 2022

    - Yolowire

  7. Diverticulitis Drugs Market Trends, Share & Size Report 2029

    3:22 a.m. Aug. 30, 2022

    - AmericaNewsHour

  8. Loading more headlines...

Rates »

Link to MarketWatch's Slice.